Consumer Alert – .gov site unreliable source of legitimate drug trials

ClinicalTrials.gov, that the public listing of medical trials on the site is not a list of trials that have been verified as legitimate by the National Institutes of Health. The National Institutes of Health is the agency that operates ClinicalTrials.gov. People tend to assume that any trials listed on ClinicalTrials.gov have been carefully screened and […]

New Treatment for Damaged Eyes

Researchers at the University of Washington have discovered a way to activate retinal cells in mice to turn into new neurons. This discovery could potentially lead to new a new treatment for human eyes that have suffered from trauma or disease. A viral gene-swapping technique was used in the study. A version of a particular […]

Some new drugs pose risk to vision

Three immune drugs, Yervoy, Opdivo, and Keytruda, may require warning labels if the FDA decides that there are risks to eye health and vision. Currently, the drugs list “uveitis” as a potential adverse effect, but the FDA has found additional complications including retinal detachment and vision loss in their post-marketing reviews of the drugs. A […]

New drug for Macular Degeneration

Genetech is currently studying a new drug, lampalizumab, to treat age-related macular degeneration. The drug is designed to slow the destruction of light-sensing cells in the retina. When those cells die, they are unable to regenerate, which causes permanent vision loss. 129 patients participated in the 18-month study and received monthly eye injections. The patients […]

Lutein levels in the eye linked to higher achievement in children

Two recent studies demonstrated that children who do better in school have higher lutein levels in the eye. Even after taking in consideration other factors including IQ, gender, body composition and physical fitness, children that had higher lutein levels did better on cognition tests and performed better academically. In the first study, researchers measured lutein […]

Optometrists more likely than ophthalmologists to recommend eye supplements

A recent study was conducted among Swedish optometrists and ophthalmologists that examined use of nutritional supplements, dietary advice, smoking and eye diseases and strength of evidence and the sources of information used for supplement recommendations. Optometrists responded at a much higher rate to the questionnaire used in the study at a rate of 40.3% compared […]

Study warns of unregulated clinics

A recent study published in the journal Cell warns of a growing number of unregulated clinics in the United States offering unregulated stem cell treatments. This alarming trend has eye care professionals urging consumers to be on alert. The unregulated clinics are able to skirt FDA oversight all because of a technicality. These clinics take cells […]

Will eyedrops replace injections for Macular Degeneration?

Researchers at the University of Birmingham have created a new eyedrop that can deliver wet macular degeneration treatment to the back of the eye. Macular degeneration causes damage to the retina at the back of the eye so this is why it is necessary for the medication to be focused on that area rather than […]

Hep C raises risk for cataracts

Study findings published in PLoS One show patients suffering from hepatitis C (HCV) infection have an increased risk of developing cataracts. Researchers from China Medical University Hospital in Tiachung, Taiwan wanted to investigate whether HCV infection was associated with a higher risk of cataract formation. Researchers analyzed database records of 11,652 patients with HCV and […]

Doctors successful retinal stem cell treatment

Doctors successfully transplanted retinal stem cells from a donor to the recipient in the first ever surgery of its type. Previously, doctors had performed a retinal stem cell transplant back in 2014 using that patient’s own skin cells that were reprogrammed. That procedure was considered a success after a year with no decline in the patient’s […]